GIA
VIVO

Gladstone Institutional Advisory’s Meridian Bioscience Inc VIVO Stock Holding History

Gladstone Institutional Advisory’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,409
Closed -$382K – 306
2020
Q2 		$382K Buy
+16,409
New +$238K 0.1% 154

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Gladstone Institutional Advisory's VIVO Position: Q3 2020 in Review

Gladstone Institutional Advisory sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 16,409 shares — an estimated $382K sold.

Gladstone Institutional Advisory first reported a position in VIVO in Q2 2020 and held it in 1 quarter. The position peaked at $382K in Q2 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Gladstone Institutional Advisory reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 16,409 Meridian Bioscience Inc shares in Q3 2020, an estimated $382K.
  • Gladstone Institutional Advisory first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 1 quarter.
  • Gladstone Institutional Advisory's Meridian Bioscience Inc position peaked at $382K in Q2 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.